|Mr. David A. Ricks||Chairman, CEO & Pres||5.12M||N/A||1968|
|Mr. Joshua L. Smiley||Sr. VP & CFO||2.37M||N/A||1970|
|Dr. Daniel M. Skovronsky||Sr. VP & Chief Scientific Officer||2.26M||N/A||1974|
|Mr. Jeffrey N. Simmons||Sr. VP & Pres of Elanco Animal Health||1.73M||N/A||1967|
|Mr. Jacob S. Van Naarden||Chief Operating Officer of Loxo Oncology||N/A||N/A||1985|
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent Bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; Avidity Biosciences, Inc.; Strateos Inc.; and National Comprehensive Cancer Network. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Eli Lilly and Company’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 9; Compensation: 2.